Iron disorders can mimic anything, so always test for them.
Routinely measuring iron status is necessary because not only are about 6% of Americans in significant negative iron balance, but about 1% have iron overload. Serum ferritin is in equilibrium with body iron stores, and is the only blood test that measures them. Barring inflammation, each one ng (0.0179 pmol) ferritin/ml of serum indicates approximately 10 mg (0.179 mmol) of body iron stores. Very early Stage I positive balance is best recognized by measuring saturation of iron binding capacity. Conversely, serum ferritin best recognizes early (Stage I and II) negative balance. Deviations from normal are: 1. Both stages of iron depletion (i.e. low stores, no dysfunction). Negative iron balance Stage I is reduced iron absorption producing moderately depleted iron stores. Stage II is severely depleted stores, without dysfunction. These stages include over half of all cases of negative iron balance. Treated with iron, they never progress to dysfunction, i.e. to disease. 2. Both stages of iron deficiency. Deficiency is inadequate iron for normal function, i.e. dysfunction, disease. Negative balance Stage III is dysfunction without anemia; Stage IV is with anemia. 3. Positive iron balance: Stage I is a multi-year period without dysfunction. Supplements of iron and/or vitamin C promote progression to dysfunction (disease). Iron removal prevents progression. Stage II is iron overload disease, encompassing years of insidiously progressive damage to tissues and organs from iron overload. Iron removal arrests progression.
Herbert
V
V
Mount Sinai School of Medicine & Medical Center, Bronx, N.Y.
D000293:Adolescent; D000328:Adult; D000747:Anemia, Hypochromic / Q000097:blood / Q000453:epidemiology; D001205:Ascorbic Acid / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D005260:Female; D005293:Ferritins / Q000097:blood; D005494:Folic Acid Deficiency / Q000150:complications; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D015791:HLA-A3 Antigen / Q000235:genetics; D006432:Hemochromatosis / Q000097:blood / Q000453:epidemiology / Q000235:genetics; D006801:Humans; D015994:Incidence; D007223:Infant; D007249:Inflammation / Q000097:blood; D007501:Iron / Q000009:adverse effects / Q000097:blood*; D000090463:Iron Deficiencies; D008297:Male; D008875:Middle Aged; D011247:Pregnancy
D015791:HLA-A3 Antigen; D005293:Ferritins; D007501:Iron; D001205:Ascorbic Acid